The primary objective is to describe eosinophil infiltration in resected (early stage) NSCLC. Secondary objectives are: * to investigate the correlation of T-Eos and B-Eos in the aforementioned patient population; * to investigate the correlation between T-Eos and overall \& disease-free survival; * to investigate the localization of T-Eos (periphery vs. center of the tumor lesions).
Study Type
OBSERVATIONAL
Enrollment
316
CHU de Liege
Liège, Belgium
Percentage of tumor associated tissue eosinophilia by immunohistochemistry and computerised quantification
Time frame: October 2022
to investigate the correlation of tissue (T)-Eos and blood (B)-Eos in the aforementioned patient population
Tissue and blood eosinophil correlation
Time frame: December 2022
to investigate the correlation between T-Eos and overall & disease-free survival
overall and disease-free survival
Time frame: December 2022
to investigate the localization of T-Eos (periphery vs. center of the tumor lesions)
tissue eosinophil localisation
Time frame: December 2022
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.